New EHR alert aims to catch silent liver damage in primary care

NCT ID NCT07159386

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a simple electronic health record alert can help primary care doctors identify patients with fatty liver disease who may have advanced liver scarring. The alert prompts doctors to calculate a risk score and, if needed, order a special ultrasound to check for fibrosis. Researchers will track how often doctors use the tool and how many cases of advanced fibrosis are detected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EHR alert and clinical decision support tool
What this could lead to
If successful, this could lead to a simple, scalable way for primary care doctors to catch serious liver scarring early in people with fatty liver disease.
What could go wrong
This is an early-stage implementation study, not a treatment trial. The alert may not change doctor behavior or improve patient outcomes, and results may not apply outside this health system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.